Breakdown | |||
TTM | Jun 2024 | Jun 2023 | Jun 2022 |
---|---|---|---|
Income Statement | Total Revenue | ||
61.10M | 64.00M | 40.20M | 24.46M | Gross Profit |
53.00M | 47.00M | 24.30M | 16.31M | EBIT |
52.20M | 44.10M | 33.80M | 52.93M | EBITDA |
26.60M | 49.40M | 33.80M | 52.93M | Net Income Common Stockholders |
-3.50M | 6.90M | 20.20M | 49.61M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||
4.70M | 19.90M | 7.60M | 2.69M | Total Assets |
1.46B | 1.44B | 1.72B | 693.60M | Total Debt |
491.70M | 481.10M | 703.70M | 22.29M | Net Debt |
487.00M | 461.20M | 696.10M | 19.60M | Total Liabilities |
519.80M | 521.50M | 766.20M | 39.51M | Stockholders Equity |
931.00M | 912.60M | 951.20M | 654.09M |
Cash Flow | Free Cash Flow | ||
15.40M | 6.40M | 888.90M | -473.92M | Operating Cash Flow |
15.40M | 6.40M | 11.10M | 19.96M | Investing Cash Flow |
138.70M | 41.50M | -961.90M | -522.47M | Financing Cash Flow |
-117.70M | -35.60M | 944.10M | 501.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $2.83B | 10.89 | 0.42% | 9.23% | 5.94% | -21.26% | |
58 Neutral | AU$418.13M | 78.69 | -0.39% | 11.05% | -14.19% | -115.93% | |
$7.45B | 10.95 | 7.73% | 4.99% | ― | ― | ||
$5.84B | 275.06 | 1.03% | 1.61% | ― | ― | ||
$4.82B | ― | -9.22% | 3.39% | ― | ― | ||
61 Neutral | AU$1.89B | ― | -10.45% | 9.03% | 2.70% | -8.39% | |
57 Neutral | AU$9.80M | ― | ― | ― | ― |
HealthCo Healthcare & Wellness REIT and the Unlisted Healthcare Fund have agreed to a short-term partial rent deferral with Healthscope and its Receivers to ensure the continuity of services at 11 private hospitals. This agreement includes immediate payment of outstanding rents for March and April 2025, and 85% of rent for May 2025, with the remaining 15% deferred until September 2025. The landlords are also in discussions about the Healthscope sale process and have received interest from other hospital operators to re-tenant the facilities, indicating a strategic move to maintain operations and explore new partnerships.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT (ASX:HCW) and the Unlisted Healthcare Fund (UHF) have announced that two entities within the Healthscope group have entered into receivership and administration. However, the entities that HCW and UHF contract with remain operational and unaffected by the receivership. The existing legal rights of HCW and UHF, including cross default and termination rights, remain intact, although termination rights are not currently enforceable. This situation underscores the resilience of HCW’s operations and its strategic positioning in the healthcare property market, ensuring stakeholders that their investments remain secure despite the challenges faced by Healthscope.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HMC Capital presented at the 2025 Macquarie Australia Conference, highlighting its strategic focus and operational strengths. The presentation underscores HMC Capital’s ability to manage substantial funds and execute complex deals, reinforcing its position in the alternative asset management industry and its commitment to delivering strong returns for its investors.
HealthCo Healthcare & Wellness REIT announced the cessation of 10,827,051 ordinary units, which were canceled as part of an on-market buy-back program completed on December 31, 2024. This strategic move is likely aimed at optimizing the company’s capital structure and potentially enhancing shareholder value, reflecting a proactive approach in managing its financial resources.
HealthCo Healthcare & Wellness REIT has completed a buy-back of 18,188,371 ordinary units, with a total consideration of AUD 20,151,127.44. This buy-back, finalized on April 22, 2025, reflects the company’s strategic decision to manage its capital structure, potentially enhancing shareholder value and signaling confidence in its financial position.
HealthCo Healthcare & Wellness REIT announced a change in the address of its registry office, effective from April 14, 2025, moving to a new location in Sydney. This operational update is part of their compliance with ASX Listing Rules and is expected to have minimal impact on stakeholders as contact details remain unchanged.
HealthCo Healthcare and Wellness REIT announced that it will not declare a quarterly distribution for the period from January 1, 2025, to March 31, 2025, in order to maintain balance sheet flexibility. The company remains committed to maximizing long-term value for its unitholders and ensuring the continuity of essential healthcare services to the Australian community.